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Summary.-Antibody was detected by membrane immunofluorescence tests in
sera of rats bearing an ascitic variant of a transplanted hepatoma, and in concen-
trated cell-free ascitic fluid. Ascites hepatoma cells were also shown to have
immunoglobulin, possibly tumour specific antibody, bound to their surface. The
kinetics of antibody responses to ascites hepatoma and hepatoma cells from solid
tumours were compared: both tumour types gave positive reactions by the third
day after implantation; antibody was present throughout subsequent tumour
growth with the ascites whereas antibody was not detected after tumour became
palpable in rats injected with hepatoma cells from solid tumour. Antibody
responses to ascites tumour were investigated in rats bearing solid hepatoma
tumour. Subcutaneous hepatoma did not influence the antibody response to ascites,
but rats bearing intraperitoneal tumours showed a diminished serum antibody
response to ascitic hepatoma.
AsCITIC variants of animal tumours
are widely used in experimental cancer
research; carriage of tumours as trans-
planted lines is simple with this form of
growth, which also provides a convenient
source of monodisperse cells. However,
there are few studies of the distinctive
immunological properties of ascitic vari-
ants derived from solid tumours, especially
in syngeneic systems. The present paper
describes serum antibody responses de-
tectable by membrane immunofluores-
cence to an ascitic hepatoma trans-
planted in syngeneic rats.
The immunology of azo dye induced
hepatomata transplanted as solid tumours
has been studied extensively in this
laboratory. A notable feature of these
tumours is an individual antigenicity,
which was detected initially by trans-
plantation techniques (Baldwin and Bark-
er, 1967a). Sera from hepatoma immune
rats were subsequently shown to contain
antibody detectable by membrane im-
munofluorescence on viable hepatoma
cells and these reactions were also shown
to be specific for the immunizing hepatoma
(Baldwin and Barker, 1967b). Tumour
specific cytotoxicity against cultured hepa-
toma cells has been demonstrated using
serum or lymph node cells from hepatoma
immune rats (Baldwin and Embleton,
1971). More recently, tumour specific
immune responses have been investigated
in rats bearing progressively growing
hepatoma (Baldwin, Embleton and
Robins, 1973b; Baldwin, Price and Robins,
1973c), including definition of serum
factors blocking cellular cytotoxicity
(Baldwin, Price and Robins, 1972, 1973d;
Robins and Baldwin, 1974).
The following study illustrates some
of the features of the antibody response
to an ascitic variant of hepatoma D23
and the interaction of that response
with the growth of the same hepatoma as
a solid tumour.
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MATERIALS AND METHODS
Rats and tamours.-The syngeneic strain
of Wistar rats and hepatomata induced by
4-dimethylaminoazobenzene used in these
studies have been described previously
(Baldwin, Embleton and Robins, 1973a).
An ascitic variant of hepatoma D23 (D23As)
was developed by intraperitoneal injection
of 107 viable hepatoma cells obtained by
trypsinization of subcutaneous tumour, fol-
lowed by weekly passage to syngeneic
recipients. Within 5 passages the hepatoma
grew as a single cell suspension in the peri-
toneal cavity, without formation of tumour
nodules. The experiments with D23As re-
ported in this paper were performed between
passages 30 and 65.
Hepatoma immunization.-Syngeneic rats
were immunized against transplanted hepato-
matabyimplantationofirradiated (15,000rad)
tumour grafts at 2-week intervals. This was
followed by monthly challenge with 5 x 105
viable hepatoma cells.
Membrane immunoftuorescence tests.-The
indirect membrane immunofluorescence test
was performed with viable hepatoma cells
in suspension as previously described (Bald-
win and Barker, 1967b). Fluorescence indices
were calculated for test sera by determining
the percentage of cells unstained with
control normal rat serum minus the per-
centage of cells unstained with the test
serum divided by the former figure. Statistical
consideration ofdata obtained with hepatoma
D23 has shown that a fluorescence index
of greater than 0 3 may be taken to represent
a significant reaction.
Mixed cell agglutination reaction.-Sheep
erythrocytes were washed 3 times with
phosphate buffered saline (PBS) pH 7-2
and resuspended to give a 2% v/v suspension.
A sub-agglutinating dilution of a rat anti-
serum to sheep erythrocytes was then
mixed with an equal volume of 2% erythro-
cyte suspension and incubated at room
temperature for 10 min. The erythrocytes
w"ere then washed 3 times in PBS and
resuspended at a concentration of 1%. To
this suspension was added an excess of a
rabbit antiserum to rat immunoglobulin
(1 ml undiluted antiserum to 15 ml erythro-
cyte suspension). After 15 min incubation
at room temperature, the erythrocytes were
washed 3 times in PBS and resuspended at a
concentration of 10%.
Hepatoma cells were brought into suspen-
sion as in the immunofluorescence test.
After incubation of 5 x 106 viable tumour
cells with 01 ml of test serum, the tumour
cells were washed 4 times with Hanks' BSS
and resuspended in 0 5 ml of Hanks' BSS.
Sensitized sheep erythrocyte suspension (0 5
ml) was then added and the mixture incu-
bated at +4°C for 18-24 h. Cell pellets
were then gently resuspended and examined
for agglutination. Positive reactions were
usually observed as rosettes although tumour
cells with 2 or more erythrocytes attached
were counted as positive. Duplicate counts
of at least 100 cells were made; if these did
not agree to within 5%, further counts
were made.
RESULTS
An ascitic variant of hepatoma D23
(D23As) was originally developed as a
source of monodisperse cells for use
in membrane immunofluorescence tests.
However, it was observed that ascites
hepatoma cells bound fluorescein con-
jugated rabbit antiserum to rat immuno-
globulin without pretreatment with im-
mune rat serum, indicating that the
cells were proliferating with rat Ig,
possibly antibody, coating their surface.
This observation led to an investigation
of antibody responses to D23As.
Table I shows results of immuno-
fluorescence tests with serum from rats
bearing D23As, and concentrated ascitic
TABLE I. Membrane Immnunofluore.scence Te8ts uith Serum and Cell-free Ascitic
Fluidfrom Rats bearing D23As
Serum from D23As rats
Concentrate(d ascitic fluid
from D23As rats
Fluorescence index with target cells from:
D23 D30 D31 D33 D44
0-5610 13 0 09 0*02,0 00 -
0-56,0 54 - 0 00 0 00,0 05 0 00
D109
0*00
0-11
22RESPONSES TO AN ASCITIC VARIANT OF RAT HEPATOMA D23
fluid, using hepatoma cells trypsinized
from solid tumour as target cells. Ascitic
fluid was separated from cellular elements
by centrifugation and concentrated to
approximately one-tenth volume against
Aquacide (Calbiochem). Both serum and
ascitic fluid gave positive fluorescence
indices with hepatoma D23 target cells
but were consistently negative when
tested against other hepatomata.
Ig coating of D23As cells
As mentioned above, the presence
of an antibody coating on D23As cells
was initially indicated by uptake of
fluorescein conjugated rabbit anti-rat Ig.
D23As cells washed in BSS were also
tested with fluorescein conjugates of other
specificities and were retested after wash-
ing with Ca++-free Locke's solution. As
shown in Table II, D23As cells washed
TABLE II. Membrane Staining of D23As
Cells by Fluorescein Conjugated Anti-
immunoglobulin Antisera
Target cell
D23As, washed
BSS
D23As, washed
Ca++-free
Locke's solution
Fluorescein
conjugate
Rabbit anti rat Ig
Goat anti rabbit Ig
Horse anti human Ig
Rabbit anti rat Ig
Goat anti rabbit Ig
Horse anti human Ig
% Cells
stained
83
1
20
10
12
26
in BSS were stained by anti-rat Ig
conjugate but not by the other conjugates.
However, after washing the D23As cells
in Ca++-free Locke's solution, none of
the conjugates gave strong staining.
Further evidence for an immuno-
globulin coating of D23As cells was
obtained using a mixed cell agglutination
test. The sensitivity and specificity of
the technique are illustrated by the
results in Table III. Treatment of target
hepatoma cells with serum from rats
immunized against the corresponding he-
patoma gave greater than 50%0 agglutina-
tion with sheep erythrocytes sensitized
against rat Ig whereas treatment with
normal serum, or serum from a rat
TABLE III.-Mixed Cell Agglutination
Reactions with Cells of DAB Induced
Hepatomata
Serum used
to treat
Target cell target cell
D23 Normal rat
D23 immune
D23As
D23
D31
D33
Normal rat
D23 immune
D31 immune
D33 immune
D23As
Normal rat
D23 immune
D31 immune
D33 immune
D23As
Normal rat
D23 immune
D31 immune
D33 immune
D23As
% Cells*
showing
agglutination
28
76
62
13
54
23
20
51
11
16
52
32
21
0
0
17
54
0
* See AMaterials and Methods.
immune to a different hepatoma, gave
less than 30%0 agglutination. Serum from
D23As bearing rats also gave positive
agglutinatioii reactions with hepatoma
D23 but not with D31 or D33, thus
confirming the individual specificity of
the antibody response to D23As indicated
in immunofluorescence tests (Table I).
D23As cells were then examined by
the mixed agglutination test and the
results of a representative test are shown
in Table IV. Ascites cells washed with
BSS formed rosettes with sensitized sheep
erythrocytes but not after washing with
TABLE IV.-Mixed Cell Agglutination
Reactions with D23As Cells
Target cell pretreatment
Washed Hanks' BSS
Washed Ca++-free Locke's solution
Washed Ca++-free Locke's solution
incubated with normal rat serum
Washed Ca++-free Locke's solution
incubated with D23As bearer
serum
* See Materials and Methods.
0 Cells*
showing
agglutination
76
26
28
61
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Ca++-free Locke's solution. This reflects
the loss of staining with fluorescein
conjugated anti-Ig antisera observed after
washing with Ca++-free Locke's solution
(Table II). Treatment of D23As cells
washed with Locke's solution with normal
rat serum did not give agglutination
but agglutination was observed after
treatment with D23As bearer serum.
The results ofthe mixed cell agglutina-
tion reaction clearly confirm those ob-
tained by membrane immunofluorescence,
showing that D23As cells grow coated
with immunoglobulin. To give an indica-
tion whether this immunoglobulin is
specifically bound or passively adsorbed,
the availability of D23 specific antigen at
the surface of D23As cells was determined
by absorption of D23 specific antibody,
assayed by membrane immunofluores-
cence. Aliquots of syngeneic immune
serum were absorbed with D23As cells
washed with BSS, D23As washed with
Ca++-free Locke's solution and D23 cells
prepared by trypsinization ofsolid tumour.
Absorbed sera were then tested against
0-6
x 05 Lu
z
0-4_
z
LU 0-3 ---------------
u
ae 0-2
-
0
-J
U-
trypsinized D23 cells in the immuno-
fluorescence test and the results are
shown in Fig. 1. D23As cells washed
with BSS did not reduce the fluorescence
index of the immune serum below 0 3
even when 5 x 107 cells per ml serum
were used. Ca++-free Locke's washed
D23As cells absorbed D23 specific anti-
body but not as effectively as cells
prepared from the solid tumour by
trypsinization. These results show that
free tumour antigen is not available on
D23As washed with BSS, and this is
consistent with the hypothesis that im-
munoglobulin at the cell surface is tumour
specific antibody bound to tumour antigen
although nonspecifically bound immuno-
globulin could prevent specific binding by
steric hindrance.
Time course study of the serum antibody
response to D23As
The antibody response to D23 specific
antigen of rats injected with D23As,
D23As cells after 60Co irradiation (15,000
rad) and D23 cells trypsinized from solid
Log cells per ml serum
10
FIG. 1.-Absorption of hepatoma specific antibody by hepatoma D23 cells. *0 * D23As cells
washed in Hanks' BSS used for absorption; A * D23As cells washed with Ca++-free Locke's
solution; * --* D23 cells trypsinized from solid tumour. Aliquots of syngeneic immune
serum were incuibated with varying numbers of each cell preparation for 30 min at room tem-
perature. Cells were removed by centrifugation and siipernatants teste(l against viable D23
cells in suspension in the membrane immunofluorescence test.
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DAYS AFTER INJECTION
FIG. 2.--Antibody responses to hepatoma
D23 cells injected intraperitoneally.
* * viable ascitic hepatoma (D23As),
107 cells; 0 *irradiated (15,000 rad)
D23As, 107 cells; A -Aviable hepatoma
D23 cells trypsinized from solidi tumouir,
107 cells. Groups contained 5 rats and
sera obtained from each rat obtained by tail
bleeding were tested individually in the
membrane immuniofluorescence test.
tumour, are shown in Fig. 2. Positive
fluorescence indices were obtained on
Day 3 after injection of all 3 types of
hepatoma D23 cells. Highest indices
were obtained with sera from rats injected
with viable D23As and these sera re-
mained positive during the subsequent
progressive growth of the ascitic hepa-
toma. In contrast, weaker reactions were
obtained in rats injected with irradiated
D23As and by Day 6 the response was
already declining. Sera from rats in-
jected with trypsinized D23 cells gave
positive fluorescence indices until Day 8
but after this stage sera were negative.
Solid intraperitoneal hepatoma was pal-
pable from the approximate time ofdisap-
pearance of serum antibody detectable
by membrane immunofluorescence.
The interaction of the antibody re-
sponse to D23As with the growth of
D23 as a solid tumour is illustrated in
Fig. 3. Solid tumours were produced
by intraperitoneal injection of tumour
mince (D23 i.p.), or subcutaneous implan-
tation of a tumour graft (D23 s.c.).
Antibodies were not detected in sera of
rats inoculated with solid tumour alone.
Groups of rats were injected with l07
D23As cells 6 days after administration
of solid tumour and in the case of D23 i.p.
tumour bearing rats the average fluores-
cence index was below 0 3 although some
sera gave positive reactions. In contrast,
sera from rats injected with D23As
6 days after D23 s.c. gave positive
fluorescence indices very similar to those
from rats injected with D23As alone.
DISCUSSION
The experiments reported in this
paper show that rats bearing a syngeneic
ascitic hepatoma (D23As) develop a strong
antibody response to the tumour specific
antigen of this hepatoma. Thus, free
antibody detectable by membrane im-
munofluorescence was present in the
serum from the third day after implanta-
tion of viable hepatoma cells and sera
gave positive reactions throughout subse-
quent tumour growth. Also, ascites hepa-
toma cells were shown to have immuno-
globulin at their surface, and absorption
experiments indicate that this immuno-
globulin may be specific antibody bound
to cell surface tumour antigen.
There are few previous reports con-
cerning specific antibody production in
response to ascitic variants of solid
tumours. Thunold (1968) studied Ehrlich
ascites tumour using membrane immuno-
fluorescence, an antiglobulin consumption
test, and a form of mixed cell agglutina-
tion technique. Ehrlich ascites tumour
cells were shown to be coated with
immunoglobulin but antibody could not
be detected in the serum of ascites bearing
mice.
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FIG. 3.-Antibody responses to D23As in rats bearing hepatoma D23 as a solid tumour. * U
subcutaneous solid tumour alone; - subcutaneous D23 tumour with D23As; *-0
intraperitoneal tumour alone; 0 O intraperitoneal D23 tumouir with D23As; A A
D23As alone. D23As (107 cells) was injected 6 days after implantation of solid tumour graft.
Time axis shows interval after injection of D23As. Groups contained 5 rats and sera obtained by
tail bleeding were tested individually in the membrane immunofluorescence test.
The antibody response to irradiated
D23As was weaker and more short-lived
than the response to untreated ascites
cells. This may indicate that viable
hepatoma cells must be present in the
peritoneal cavity for sustained stimula-
tion of antibody production. The anti-
body response to trypsinized D23 cells
was also strong when a viable single cell
suspension was present in the peritoneal
cavity, but antibody was not detected
after the appearance of solid tumour.
This disappearance of antibody could
be interpreted as an absorption of cir-
culating antibody by the cells of the
tumour mass; further evidence on this
point is provided by the experiments with
concurrently growing ascites and solid
tumour.
Serum antibody was not detected
regularly in rats bearing D23 intraperi-
toneal tumours and subsequently injected
with D23As. This could again reflect
absorption of antibody by the tumour
mass; however, the injected D23As cells
may have aggregated to the solid intra-
peritoneal tumour, no longer providing
the immunogenic stimulation of dispersed
ascites cells. The antibody response to
D23As in rats bearing subcutaneous D23
was very similar to that of normal rats.
In this case, the growth pattern of the
ascites is not influenced by the solid
tumour, providing an immunogenic stimu-
lus comparable with D23As in normal
rats. The strong antibody response to
D23As in D23 s.c. tumour bearing rats
indicates that the tumour antigen within
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the tumour mass is not available for
absorption of antibody from the cir-
culation.
Recent studies of serum antibody
and antigen during the growth of hepa-
toma D23 as solid subcutaneous and
intraperitoneal tumours are relevant to
these facts. With subcutaneous tumours,
free antigen was present in the early
stages of growth (7-10 days after tumour
implantation). This was followed by a
phase when immune complexes were
present, and finally, free antibody was
detected in the terminal stages of tumour
growth (Bowen, Robins and Baldwin,
1974). With intraperitoneal hepatoma,
serum is in antigen excess throughout
tumour growth (Baldwin, Bowen and
Price, 1973a). Thus the rate of antigen
release by solid tumour is dependent on
the site of growth, and this in turn
could influence the serum antibody level
during the simultaneous growth of ascites
and solid tumours.
These considerations emphasize the
complexity of the interaction between
tumour growth, the host response and
serum factors present at a given stage
of tumour development. Model systems
such as the syngeneic rat hepatoma should
allow elucidation of these interactions
and their possible influence on tumour
growth.
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